Citation Impact
Citing Papers
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
2020 StandoutScience
The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung
2005 StandoutNobel
Idiopathic Pulmonary Fibrosis: Current Concepts
1998
Idiopathic pulmonary fibrosis
2017 Standout
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Toll-like receptor pathways in the immune responses to mycobacteria
2004
Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice
2009
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
2008
Higher Monocyte Expression of TLR2 and TLR4, and Enhanced Pro-inflammatory Synergy of TLR2 with NOD2 Stimulation in Sarcoidosis
2008
Comparative effects of cilostazol and other therapies for intermittent claudication
2001
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis
2007
Wound repair and regeneration
2008 StandoutNature
Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis
2008
Lymphatic filariasis and onchocerciasis
2010 Standout
Melioidosis
2003 Standout
Sarcoidosis and granuloma genes: a family-based study in African-Americans
2004
Influence of Alternatively and Classically Activated Macrophages on Fibrogenic Activities of Human Fibroblasts
2000
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
2003
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
pH-dependent Conformational Flexibility of the SARS-CoV Main Proteinase (Mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses
2005
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Ivermectin: uses and impact 20 years on
2006
Severe Sepsis and Septic Shock
2013 Standout
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
An Approach to the Treatment of Pulmonary Sarcoidosis With Corticosteroids
1999
Nonresolving Inflammation
2010 Standout
Genotype-corrected reference values for serum angiotensin-converting enzyme
2006
Mechanistically Identified Suitable Biomarkers of Exposure, Effect, and Susceptibility for Silicosis and Coal-Worker'S Pneumoconiosis: A Comprehensive Review
2006
Sarcoidosis
2013 Standout
Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study
2011
Sarcoidosis
2003
Sleep Deprivation Effects on Circadian Clock Gene Expression in the Cerebral Cortex Parallel Electroencephalographic Differences among Mouse Strains
2008 StandoutNobel
Inflammatory Bowel Disease
2002 Standout
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
2009
Diabetes and Atherosclerosis
2002 Standout
Sarcoidosis
2011
Alveolar macrophages: plasticity in a tissue-specific context
2014
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
2011
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene
1999
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis
1997
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
1994
Inhibitation of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline
1996
Emerging Biological Principles of Metastasis
2017 Standout
Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
2003
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Inflammation and cancer: back to Virchow?
2001 Standout
Genetic predisposition to respiratory infection and sepsis
2011
Sleep: A Physiologic Role for IL‐1β and TNF‐αa
1998
Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis
2010
Idiopathic Pulmonary Fibrosis
2001 Standout
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
2009
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
2009
HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
2015 StandoutNobel
Airway Mucus Function and Dysfunction
2010 Standout
IgG4-related disease
2014 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Tumour Necrosis Factor in Sarcoidosis and its Potential for Targeted Therapy
2003
Reactive Oxygen Metabolites (ROMs) as an Index of Oxidative Stress in Obstructive Sleep Apnea Patients
2003
Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
1998
Disseminated Intravascular Coagulation
1999 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
2006
Myeloid derived suppressor cells in human diseases
2011
Tumour necrosis factor and Crohn's disease.
1997
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen
1999
Sarcoidosis
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
2014 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Genetics of Sarcoidosis: Candidate Genes and Genome Scans
2007
Lupus Pernio in Sarcoidosis
2003
Genetics of Sarcoidosis
2008
Pathogen Recognition and Innate Immunity
2006 Standout
Genetic polymorphisms in sepsis
2005
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
2008
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
2015
Silicosis
2012 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Aerobic and Strength Training in Patients with Chronic Obstructive Pulmonary Disease
1999
Non–Mannose-capped Lipoarabinomannan Induces Lung Inflammation via Toll-like Receptor 2
2004
Results from a Genome-wide Search for Predisposing Genes in Sarcoidosis
2001
Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis
2005
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
2006
Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea
2000
Hypoxia Causes Glucose Intolerance in Humans
2004
Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis
2001
Analysis of Intracellular Cytokines in CD4 + and CD8 + Lung and Blood T Cells in Sarcoidosis
2001
Future Directions in Sarcoidosis Research
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
2000 StandoutNobel
Clues from cell metabolism
2010 StandoutNatureNobel
Steroid-resistant sarcoidosis: is antagonism of TNF-α the answer?
2007
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Assessment of Clinical Criteria for Sepsis
2016 Standout
Etanercept for Refractory Ocular Sarcoidosis
2005
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
2006
Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells
1991
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Invasive Candidiasis
2015 Standout
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Cytokine Storm
2020 Standout
A sulfated metabolite produced bystf3negatively regulates the virulence ofMycobacteriumtuberculosis
2006 StandoutNobel
Pleistocene North African genomes link Near Eastern and sub-Saharan African human populations
2018 StandoutScienceNobel
Inflammation and Atherosclerosis
2002 Standout
Absence of Diurnal Variation of C-Reactive Protein Concentrations in Healthy Human Subjects
2001
Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression
2011
Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection
1992
Pathophysiology of Sleep Apnea
2010 Standout
C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
2010
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
2005
Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.
2009
Free Radicals in the Physiological Control of Cell Function
2002 Standout
An Array-Based Method To Identify Multivalent Inhibitors
2010
Works of P. Zabel being referenced
TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens
2008
Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
2008
TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSIS
1997
OXPENTIFYLLINE IN ENDOTOXAEMIA
1989
Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A
1995
Molecular mechanisms of severe acute respiratory syndrome (SARS)
2005
The interleukin-6 −174 promoter polymorphism is associated with extrapulmonary bacterial dissemination in Streptococcus pneumoniae infection
2005
Pentoxifylline in treatment of sarcoidosis.
1997
Procalcitonin as a marker of severity in septic shock
1999
Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis
1998
Antiinflammatory and Antifibrotic Properties of Colchicine: Implications for Idiopathic Pulmonary Fibrosis
1997
Treatment and vaccines for severe acute respiratory syndrome
2005
Inhibition of endogenous TNF formation by pentoxifylline
1993
Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung
2003
Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines.
1996
Effect of Pentoxifylline in Severe Sepsis
1998
Emerging Mucus Regulating Drugs in Inflammatory and Allergic Lung Disease
2008
Fatal Outcome of a Hyperinfection Syndrome despite Successful Eradication of Strongyloides with Subcutaneous Ivermectin
2005
Tumor Necrosis Factor- α − 308 Promoter Gene Polymorphism and Increased Tumor Necrosis Factor Serum Bioactivity in Farmer's Lung Patients
2001
Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity
1998
Sarcoidosis: TNF- α Release from Alveolar Macrophages and Serum Level of sIL-2R Are Prognostic Markers
1997
Pneumococcal Septic Shock Is Associated with the Interleukin-10–1082 Gene Promoter Polymorphism
2003
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
2010
Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients
2005